ClotTriever Outcomes (CLOUT) Registry
Status: Completed
Location: See all (43) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
Evaluate real world patient outcomes after treatment of acute, subacute, and chronic proximal lower extremity deep vein thrombosis (DVT) with the ClotTriever Thrombectomy System.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Proximal lower extremity DVT involving the femoral, common femoral, iliac veins, or inferior vena cava (IVC), alone or in combination.
• Willing and able to provide informed consent.
Locations
United States
Alabama
Affinity Cardiovascular Specialists
Birmingham
St. Vincent's East
Birmingham
California
University of California, Los Angeles
Los Angeles
Vascular and Interventional Specialists of Orange County
Orange
Colorado
University of Colorado, Denver
Denver
Connecticut
Yale University
New Haven
Washington, D.c.
MedStar Health Research Institution
Washington D.c.
Florida
Manatee Memorial Hospital
Bradenton
Memorial Hospital Jacksonville
Jacksonville
Lakeland Vascular Institute
Lakeland
Mount Sinai Medical Center of Florida
Miami Beach
AdventHealth Tampa
Tampa
Georgia
Longstreet Clinic
Gainesville
Kansas
Wesley Medical Center
Wichita
Kentucky
Surgical Care Associates
Louisville
Louisiana
Lafayette General
Lafayette
Opelousas General
Opelousas
Michigan
McLaren Bay Heart and Vascular
Bay City
Millenium Cardiology
Farmington Hills
Ascension Genesys Hospital
Grand Blanc
Beaumont Health
Royal Oak
Missouri
University of Missouri
Columbia
Saint Luke's Hospital of Kansas City
Lee's Summit
Washington University at St. Louis
St Louis
New Jersey
Hackensack Meridian
Hackensack
New York
Albany Medical College
Albany
SUNY, The University at Buffalo
Buffalo
Columbia University Irving Medical Center
New York
NYU Langone Medical Center
New York
Northwell Health
Staten Island
Ohio
The Christ Hospital
Cincinnati
Mercy Health - The Heart Institute
Fairfield
Oklahoma
Oklahoma Heart Institute
Tulsa
Pennsylvania
Thomas Jefferson
Philadelphia
Allegheny Health Network Research Institute
Pittsburgh
South Carolina
Prisma Health - Upstate
Greenville
Tennessee
Methodist Healthcare Foundation
Germantown
Texas
Houston Healthcare Medical Center
Houston
University of Texas Health Sciences Center - Houston
Houston
Virginia
Sentara Vascular Specialists
Norfolk
Washington
Providence Sacred Heart
Spokane
Wisconsin
Gunderson Health
La Crosse
Aurora St. Luke's Medical Center
Milwaukee
Time Frame
Start Date: 2018-09-01
Completion Date: 2024-07-02
Participants
Target number of participants: 499
Treatments
Primary Analysis Population
Patients with unilateral acute or subacute DVT of less than or equal to 6 weeks' duration without recent (≤ 3 month) history of venous intervention.
Full Analysis Population
Subjects with proximal lower extremity DVT involving the femoral, common, femoral, iliac veins or inferior vena cava (IVC), alone or in combination.
Related Therapeutic Areas
Sponsors
Leads: Inari Medical